Drug intelligence / Profile preview

phleum pratense extract

Development stage
Approved
Lead developer
ALK Abelló
Modality
Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
Administration
Sublingual, Subcutaneous
01

Overview

Phleum pratense extract is a standardized allergenic preparation derived from the pollen of Timothy grass (Phleum pratense). It is primarily used for allergen-specific immunotherapy to treat and prevent symptoms of allergic rhinitis (hay fever) and related respiratory allergies caused by grass pollens. The mechanism of action involves desensitizing the immune system to specific allergens through repeated exposure to small amounts of the allergen. This leads to modulation of T and B cell responses and increased production of protective IgG4 antibodies that block allergic reactions[1][4][5]. Phleum pratense extract can be administered sublingually (under the tongue) or via subcutaneous injection. Prescription products such as Grazax (sublingual tablet), Alutard SQ (injectable), and Grastek are approved for use in allergy immunotherapy[1][8]. The main indication is for patients with confirmed sensitivity to Timothy grass pollen who experience seasonal hay fever with or without conjunctivitis.

Brand names
GrazaxAlutard SQGrastek
Other names
timothy grass pollen extracttimothy grass allergen extractPhleum pratense pollen extractTimothy Grass

Beyond the preview

Go deeper on phleum pratense extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on phleum pratense extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call